These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10962315)

  • 1. Is scrotal violation per se a risk factor for local relapse and metastases in stage I nonseminomatous testicular cancer?
    Aki FT; Bilen CY; Tekin MI; Ozen H
    Urology; 2000 Sep; 56(3):459-62. PubMed ID: 10962315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of scrotal violation in testicular cancer: is adjuvant local therapy necessary?
    Capelouto CC; Clark PE; Ransil BJ; Loughlin KR
    J Urol; 1995 Mar; 153(3 Pt 2):981-5. PubMed ID: 7853587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical implications of procedural deviations during orchiectomy for nonseminomatous testis cancer.
    Leibovitch I; Baniel J; Foster RS; Donohue JP
    J Urol; 1995 Sep; 154(3):935-9. PubMed ID: 7637097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis.
    Pizzocaro G; Zanoni F; Salvioni R; Milani A; Piva L; Pilotti S
    J Urol; 1987 Dec; 138(6):1393-6. PubMed ID: 2824862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.
    Daugaard G; Gundgaard MG; Mortensen MS; Agerbæk M; Holm NV; Rørth M; von der Maase H; Christensen IJ; Lauritsen J
    J Clin Oncol; 2014 Dec; 32(34):3817-23. PubMed ID: 25267754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. Danish Testicular Cancer Study Group.
    Rørth M; Jacobsen GK; von der Maase H; Madsen EL; Nielsen OS; Pedersen M; Schultz H
    J Clin Oncol; 1991 Sep; 9(9):1543-8. PubMed ID: 1714948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
    Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
    Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
    Gumus M; Bilici A; Odabas H; Ustaalioglu BBO; Kandemir N; Demirci U; Cihan S; Bayoglu IV; Ozturk T; Turkmen E; Urakci Z; Seker MM; Gunaydin Y; Selcukbiricik F; Turan N; Sevinc A
    World J Urol; 2017 Jul; 35(7):1103-1110. PubMed ID: 27812752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.
    Sturgeon JF; Moore MJ; Kakiashvili DM; Duran I; Anson-Cartwright LC; Berthold DR; Warde PR; Gospodarowicz MK; Alison RE; Liu J; Ma C; Pond GR; Jewett MA
    Eur Urol; 2011 Apr; 59(4):556-62. PubMed ID: 21190791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance in patients with stage I testicular nonseminomatous germ cell tumors.
    Gez E; Wygoda M; Nussbaum N; Figer A; Gil RI; Inbal M
    Cancer Invest; 1993; 11(1):10-4. PubMed ID: 8380748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testicular tumors in children.
    Ciftci AO; Bingöl-Koloğlu M; Senocak ME; Tanyel FC; Büyükpamukçu M; Büyükpamukçu N
    J Pediatr Surg; 2001 Dec; 36(12):1796-801. PubMed ID: 11733909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paratesticular rhabdomyosarcoma: Importance of initial therapy.
    Hammond WJ; Farber BA; Price AP; Wolden SL; Heaton TE; Wexler LH; La Quaglia MP
    J Pediatr Surg; 2017 Feb; 52(2):304-308. PubMed ID: 27894767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
    Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
    Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
    Divrik RT; Akdoğan B; Ozen H; Zorlu F
    J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 18. What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease?
    Ekenel M; Keskin S; Sanli Ö; Bavbek S; Tunç M; Ander H; Ozcan F; Kiliçaslan I; Başaran M
    Clin Genitourin Cancer; 2012 Sep; 10(3):185-9. PubMed ID: 22682983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for relapse in patients with clinical stage I testicular nonseminomatous germ cell tumors.
    Dong P; Liu ZW; Li XD; Li YH; Yao K; Wu S; Qin ZK; Han H; Zhou FJ
    Med Oncol; 2013 Mar; 30(1):494. PubMed ID: 23400963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effectiveness of Risk-adapted Surveillance vs Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: A Retrospective Follow-up Study of 81 Patients.
    Fan G; Zhang L; Yi L; Jiang ZQ; Ke Y; Wang XS; Xiong YY; Han WQ; Zhou X; Liu C; Yu X
    Asian Pac J Cancer Prev; 2015; 16(8):3267-72. PubMed ID: 25921130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.